FEBRUARY 13, 2012
UroToday
« Start  Prev  1 2345NextEnd»
ASCO 2009 - A Phase II Study of Patupilone in Patients with Metastatic Castration-Resistant Prostate Cancer who have Progressed after Docetaxel - Session Highlights Print E-mail
Wed, 03 June 2009
Login to read more...
ASCO 2009 - Analyses of Circulating Tumor Cell Dynamics and Treatment Response in Prostate Cancer Using the CTC-Chip Microfluidic Device - Session Highlights Print E-mail
Wed, 03 June 2009
Login to read more...
ASCO 2009 - Gene-Based Prediction of PSA Recurrence for Clinically Localized Prostate Cancer Patients - Session Highlights Print E-mail
Wed, 03 June 2009
Login to read more...
ASCO 2009 - Comparability of Health-Related Quality of Life, Treatment Decision Making, and Treatment Satisfaction after PSA Recurrence Among Prostate Cancer Patients who Receive Hormone Therapy Versus Observation: Results from the COMPARE Registry - Sess Print E-mail
Wed, 03 June 2009
Login to read more...
ASCO 2009 - Diabetes and the Risk of Death in Men with Favorable or High-Risk Prostate Cancer Following Radiation Therapy - Session Highlights Print E-mail
Wed, 03 June 2009

Last Updated ( Wed, 03 June 2009 )

Login to read more...
ASCO 2009 - Impact of Asian American Race on Prostate Cancer Outcomes - Session Highlights Print E-mail
Wed, 03 June 2009
Login to read more...
ASCO 2009 - C-Reactive Protein as Adverse Prognostic Marker for Men with Castration-Resistant Prostate Cancer: Confirmatory Results - Session Highlights Print E-mail
Wed, 03 June 2009
Login to read more...
ASCO 2009 - Postrandomization Analysis Assessing Survival Following Radiation Therapy with or without 6 Months of Androgen Suppression Therapy for Localized Prostate Cancer - Session Highlights Print E-mail
Tue, 02 June 2009
Login to read more...
ASCO 2009 - Local Variation in Primary Treatment of Localized Prostate Cancer - Session Highlights Print E-mail
Tue, 02 June 2009
Login to read more...
ASCO 2009 - Radical Prostatectomy in Clinically Localized Prostate Cancer – the Risk of Extraprostatic Spread by NCCN Risk Group and its Implications for Adjuvant Therapy: An Analysis of 23,988 Patients - Session Highlights Print E-mail
Tue, 02 June 2009
Login to read more...
« Start  Prev  1 2345NextEnd»
Share |